📋 Disclosure: This post contains affiliate links. We may earn a commission if you sign up through our links — at no extra cost to you. Full disclosure.

 Medical note: This content is for informational purposes only. Always consult your doctor before starting any medication. Full disclaimer.

Semaglutide side effects are the number one reason people stop treatment early — often unnecessarily. Most side effects are temporary, predictable, and manageable with the right approach. Understanding exactly what to expect, and when, makes the difference between pushing through and giving up.

This guide covers every semaglutide side effect week by week — from the first injection through month three and beyond — based on clinical trial data, FDA reporting, and real patient experiences from the GLP-1 community.

---

Quick answer: The most common semaglutide side effects are nausea, constipation, fatigue, and reduced appetite. They are most intense during weeks 1–4 as your body adjusts to each new dose. By week 8–12 the majority of patients report significant improvement. Serious side effects are rare but exist — know the warning signs.

---

How Semaglutide Causes Side Effects

Semaglutide works by activating GLP-1 receptors throughout the body — primarily in the pancreas, brain, and gastrointestinal tract. The GI effects are direct and predictable: semaglutide slows gastric emptying (the rate at which food leaves your stomach), which causes the nausea, fullness, and digestive discomfort most patients experience.

This mechanism is dose-dependent — higher doses produce stronger GI effects. This is why semaglutide is started at a low dose (0.25mg weekly) and increased gradually over months. The slow escalation protocol exists specifically to minimise side effects while allowing your GI system to adapt.

According to the FDA prescribing information for Ozempic, gastrointestinal events were reported in approximately 44% of patients in clinical trials — compared to 16% in the placebo group. Most were mild to moderate and resolved without stopping treatment.

---

Week 1 — First Injection

What most patients experience:

The first week is often the easiest — or the hardest — depending on your individual sensitivity. At the starting dose of 0.25mg, many patients feel little to nothing beyond mild reduced appetite. Others experience immediate and significant nausea.

Common week 1 side effects:

• Mild to moderate nausea — especially after eating
• Reduced appetite — often dramatic and sudden
• Mild fatigue — particularly in the first 24–48 hours after injection
• Injection site reactions — redness, itching, or mild swelling at the injection site
• Mild stomach gurgling or gas

What helps in week 1:

• Eat smaller portions than usual — your stomach empties more slowly now
• Avoid high-fat, greasy, or heavily spiced foods for the first two weeks
• Inject in the evening so any immediate nausea occurs during sleep
• Stay well hydrated — sip water constantly throughout the day
• Avoid lying down immediately after eating — wait at least 2 hours

What to expect: Week 1 nausea typically peaks 6–12 hours after injection and improves within 2–3 days. If you have no nausea in week 1, this does not mean the medication is not working.

---

Week 2 — Dose Settling

What most patients experience:

By week 2 your body has had one full week with semaglutide in its system. The second injection adds to the existing blood concentration — some patients find week 2 slightly more intense than week 1 as levels accumulate.

Common week 2 side effects:

• Nausea continues — may be slightly worse than week 1 for some patients
• Constipation begins — semaglutide slows the entire digestive system, not just the stomach
• Reduced thirst sensation — drink water even if you do not feel thirsty
• Heartburn or acid reflux — more common in patients with pre-existing reflux
• Burping — caused by slowed gastric emptying and trapped gas

What helps in week 2:

• Start a fibre supplement (psyllium husk, Metamucil) to manage constipation before it becomes severe
• Eat your protein first at every meal — it is more filling and less likely to trigger nausea than carbohydrates
• Avoid carbonated drinks — they worsen bloating and burping significantly
• Walk for 15–20 minutes after meals — gentle movement aids digestion

The constipation warning: Do not ignore constipation in week 2. It compounds quickly on semaglutide. Hydration and fibre from week 1 is the most effective prevention strategy. Many patients who struggle with constipation at week 4–6 did not address it early enough.

---

Weeks 3–4 — Adjustment Phase

What most patients experience:

Weeks 3 and 4 represent the peak adjustment period for patients staying at the 0.25mg starting dose. By this point your GI system has had enough time to either adapt — or not. Patients who are going to struggle significantly with nausea typically know by week 3.

Common weeks 3–4 side effects:

• Nausea — either improving significantly OR still significant. No middle ground by week 4.
• Constipation — may become more pronounced if not actively managed
• Food aversions — specific foods that previously had no effect now trigger immediate nausea
• Fatigue — some patients experience persistent low-level fatigue through this phase
• Headaches — dehydration-related headaches are common, often mistaken for medication side effects
• Muscle loss concern — reduced appetite can mean insufficient protein. Prioritise protein intake.

What helps in weeks 3–4:

• If nausea is still severe at week 3 — speak to your prescribing physician. Anti-nausea medication (ondansetron) can be prescribed and is safe to use with semaglutide.
• Eat 5–6 small meals rather than 3 large ones — smaller portions are dramatically easier on a semaglutide-slowed stomach
• Track protein intake — aim for at least 0.7g per pound of body weight daily to protect muscle mass
• Ginger tea, ginger chews, or ginger supplements have the best evidence base of any natural nausea remedy

A note on week 4: Many patients who discontinue semaglutide do so around week 3–4. The vast majority who push through to week 6–8 report that nausea improves substantially. The temporary discomfort of weeks 3–4 is not a sign the medication is wrong for you — it is a sign your body is adjusting to a significant pharmacological change.

---

Weeks 5–8 — Dose Increase Phase

What most patients experience:

After 4 weeks at 0.25mg, most prescribing protocols increase the dose to 0.5mg. This dose increase typically restarts the adjustment cycle — patients who had mostly settled by week 4 often experience a return of nausea at week 5 when the dose increases.

Common weeks 5–8 side effects:

• Nausea returns at week 5 with dose increase — usually milder than the week 1 experience
• Constipation may worsen at higher dose — increase fibre and water intake proactively
• Appetite suppression deepens — some patients find eating feels like an effort
• Hair shedding may begin — telogen effluvium caused by rapid weight loss and caloric restriction, not the medication directly
• Dizziness — particularly when standing quickly, caused by lower caloric intake and potential mild dehydration

Dose increase adjustment timeline: Most patients readjust to the new dose within 2–3 weeks. The pattern of each dose increase causing a brief recurrence of nausea and then improving is the standard semaglutide experience.

The hair loss question: Hair shedding on semaglutide is almost always telogen effluvium — a temporary shedding triggered by the physiological stress of rapid weight loss and significant caloric reduction. It typically begins 2–3 months after starting treatment and resolves within 3–6 months without stopping medication. Adequate protein intake (0.7g+ per pound of body weight) is the single most effective prevention measure.

---

Weeks 9–12 — Stabilisation

What most patients experience:

By weeks 9–12 the majority of patients report that GI side effects have substantially improved. Nausea is either gone or reduced to occasional mild episodes. Appetite suppression has normalised — it no longer feels shocking, it simply feels like a new baseline.

What improves by weeks 9–12:

• Nausea — resolved or significantly reduced for 70–80% of patients
• Fatigue — largely resolved as the body adapts
• Food aversions — typically reduced, though some remain permanently
• Injection site reactions — reduced as technique improves and sites rotate

What may persist or emerge:

• Constipation — can remain an ongoing issue requiring consistent management
• Hair shedding — may still be ongoing if weight loss has been rapid
• Heartburn — some patients develop persistent reflux that requires management
• Muscle loss — if protein intake has been insufficient through weeks 1–12

The muscle preservation warning: By week 12, if you have not been prioritising protein intake and resistance exercise, a significant portion of your weight loss may have come from muscle rather than fat. This is the most common long-term health issue with semaglutide that is entirely preventable. Aim for 0.7–1g of protein per pound of body weight daily and include resistance training 2–3 times per week.

---

Month 4 and Beyond

What long-term semaglutide users experience:

Beyond month 3, semaglutide side effects for most patients have settled into a predictable pattern. Each dose increase triggers a brief return of GI symptoms followed by adaptation.

Long-term considerations:

Plateau effect: Weight loss typically slows after months 4–6 as the body adapts. This is not a side effect — it is expected pharmacology. Dose increases (if clinically appropriate) or dietary adjustments address this.

Semaglutide face: Rapid facial fat loss is common with significant weight loss on GLP-1 medications. This is not a medication side effect — it is a consequence of overall fat loss. Adequate protein intake and resistance training help maintain facial volume.

Psychological effects: Many long-term users report reduced interest in food, reduced “food noise” (constant thinking about food), and changed relationship with eating. These are largely reported as positive by patients but can occasionally manifest as disordered eating patterns in vulnerable individuals.

Stopping semaglutide: Weight regain after stopping is significant and well-documented. Clinical trial data shows most patients regain the majority of lost weight within 12 months of stopping. This is not a moral failing — it reflects the ongoing nature of obesity as a condition requiring long-term management.

---

Side Effects by Type — Full Guide

Nausea

Frequency: 44% of patients
Peak timing: Weeks 1–4, returns briefly with each dose increase
Duration: Typically resolves by week 8–12
Management: Small meals, low-fat foods, ginger, evening injections, ondansetron if prescribed

Constipation

Frequency: 24% of patients
Peak timing: Begins week 2, can persist throughout treatment
Duration: Ongoing — requires consistent management
Management: Psyllium husk, increased water intake, movement after meals, MiraLax if needed

Diarrhoea

Frequency: 9% of patients (less common than constipation)
Peak timing: Weeks 1–4
Duration: Usually resolves by week 6
Management: BRAT diet temporarily, hydration, avoid high-fat foods

Fatigue

Frequency: Common in weeks 1–4
Peak timing: First 48 hours after each injection
Duration: Typically resolves by week 4–6
Management: Injection timing (evening), adequate sleep, hydration, protein intake

Headaches

Frequency: Common
Peak timing: Throughout treatment
Duration: Usually dehydration-related — resolves with hydration
Management: Increase water intake significantly — aim for 2.5–3 litres daily

Hair shedding

Frequency: Reported by 30–50% of patients
Peak timing: Months 2–4
Duration: Resolves within 3–6 months in most patients
Management: Adequate protein intake, biotin supplement, gentle hair care

Heartburn/reflux

Frequency: 8% of patients
Peak timing: Can begin any time
Duration: May persist throughout treatment
Management: Avoid lying down after eating, elevate head of bed, antacids, PPI if prescribed

Injection site reactions

Frequency: 5% of patients
Peak timing: Early weeks
Duration: Usually resolves as technique improves
Management: Rotate injection sites, allow medication to reach room temperature before injecting, use 4mm needle

---

Serious Side Effects — When to Call Your Doctor

These side effects are rare but require immediate medical attention. Do not manage these at home.

Call your doctor or 911 immediately if you experience:

Pancreatitis signs:
Severe abdominal pain that radiates to your back, with or without vomiting. Pancreatitis is a rare but serious GLP-1 complication. Reported in less than 1% of patients but requires emergency treatment.

Thyroid tumour signs:
A lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath. Semaglutide carries an FDA black box warning for thyroid C-cell tumours based on rodent studies. The risk in humans has not been confirmed but is a contraindication for patients with personal or family history of medullary thyroid carcinoma or MEN 2.

Severe allergic reaction:
Rash, itching, swelling of face/lips/tongue/throat, difficulty breathing. Stop medication and seek emergency care immediately.

Vision changes:
Sudden changes in vision, blurred vision, or eye pain. Diabetic retinopathy worsening has been reported in some patients. Report any vision changes to your doctor promptly.

Gallbladder problems:
Severe upper right abdominal pain, fever, and jaundice. Cholelithiasis (gallstones) risk is increased with rapid weight loss.

Kidney problems:
Significant reduction in urination, swelling in legs and feet, persistent nausea combined with fatigue. Dehydration from GI side effects can stress kidneys in vulnerable patients.

---

What Actually Helps — Evidence-Based Tips

These are the interventions with the strongest evidence base for managing semaglutide side effects:

For nausea:

• Inject in the evening — sleep through the peak nausea window
• Eat protein first at every meal
• Avoid high-fat, fried, or heavily seasoned foods
• Ginger — tea, chews, or 250mg supplements — best natural evidence
• Eat every 3–4 hours — empty stomach worsens nausea
• Ondansetron — ask your doctor, safe with semaglutide, highly effective

For constipation:

• Psyllium husk (Metamucil) daily from week 1 — do not wait for constipation to start
• 2.5–3 litres of water daily minimum
• 15–20 minute walk after each meal
• MiraLax (polyethylene glycol) — gentle, effective, safe long-term

For fatigue:

• Prioritise sleep — 7–9 hours nightly
• Inject Thursday or Friday evening so fatigue falls on weekend
• Adequate protein — fatigue is often partly nutritional

For hair loss:

• 0.7–1g protein per pound of body weight daily — most important intervention
• Biotin 5000mcg daily
• Gentle hair washing — reduce mechanical stress
• This resolves on its own — treatment is rarely needed

For headaches:

• Track water intake — most semaglutide headaches resolve with proper hydration
• Electrolytes — sodium, potassium, magnesium — particularly if sweating or exercising

---

Key Takeaways

• Semaglutide side effects are most intense in weeks 1–4 and after each dose increase
• Nausea affects approximately 44% of patients and resolves for most by week 8–12
• Constipation requires active management from week 1 — do not wait for it to develop
• Hair shedding is caused by rapid weight loss, not the drug — adequate protein is the best prevention
• Serious side effects are rare but real — know the warning signs
• The majority of patients who push through weeks 3–4 report that side effects improve substantially
• Never stop semaglutide abruptly without speaking to your prescribing physician

---

Frequently Asked Questions

How long do semaglutide side effects last?

For most patients, the worst GI side effects — nausea, vomiting, and fatigue — resolve or reduce significantly by weeks 8–12. Constipation can persist throughout treatment and requires ongoing management. Each dose increase triggers a brief return of side effects followed by adaptation within 2–3 weeks.

Does everyone get side effects on semaglutide?

No. Approximately 44% of patients in clinical trials reported nausea compared to 16% on placebo. That means more than half of patients experience mild or no GI side effects. Individual sensitivity varies significantly based on genetics, body weight, diet, and injection technique.

Is nausea a sign that semaglutide is working?

Not necessarily. Nausea is a side effect of GI system slow-down — not a direct indicator of weight loss efficacy. Patients with no nausea lose the same amount of weight as those with significant nausea. The absence of nausea does not mean the medication is not working.

Can I take anti-nausea medication with semaglutide?

Yes. Ondansetron (Zofran) is commonly prescribed alongside semaglutide for patients with significant nausea and is safe to use. Over-the-counter options including dimenhydrinate (Dramamine) and meclizine can also help. Always confirm with your prescribing physician before adding any medication.

Why do side effects come back when I increase my dose?

Each dose increase exposes your GI system to a higher level of GLP-1 receptor activation than it has adapted to. The re-adaptation process takes 2–3 weeks at each new dose level. This restart of mild side effects with each increase is normal and expected — it is not a sign that the higher dose is wrong for you.

Should I stop semaglutide if side effects are severe?

Do not stop without speaking to your prescribing physician first. Severe or persistent side effects (particularly vomiting, inability to eat, or significant dehydration) should be reported immediately. Your physician may recommend staying at the current dose longer before increasing, taking a brief dose reduction, or prescribing anti-nausea medication. Abrupt discontinuation is rarely necessary.

Does semaglutide cause permanent side effects?

No permanent side effects from semaglutide have been established in clinical evidence as of 2026. The thyroid tumour risk seen in rodent studies has not been confirmed in human trials. Hair loss resolves. GI effects resolve. The FDA continues to monitor long-term safety data.

---

Sources: FDA Prescribing Information for Ozempic and Wegovy (2026 update), NEJM SUSTAIN and STEP trial data, FDA Adverse Event Reporting System (FAERS) semaglutide data 2026, CDC obesity treatment guidelines 2025.

Written and reviewed by the SemaglutideEdge editorial team. Last updated August 2, 2026.